Mechanical regulation of epigenetics in vascular biology and pathobiology

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 4, 2013, Pages 437-448

  Chen, Li Jing ^a,b   Wei, Shu Yi ^a   Chiu, Jeng Jiann ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TSING HUA UNIVERSITY   (Taiwan)

Author keywords

Endothelial cells; Epigenetics; Mechanotransduction; Shear stress; Smooth muscle cells

Indexed keywords

HISTONE; HISTONE DEACETYLASE; MICRORNA;

ANGIOGENESIS; ANIMAL; ARTICLE; BIOMECHANICS; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; GENETIC EPIGENESIS; GENETICS; HEMODYNAMICS; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHYSIOLOGICAL STRESS; PHYSIOLOGY; PROTEIN PROCESSING;

ANIMALS; BIOMECHANICAL PHENOMENA; CHROMATIN ASSEMBLY AND DISASSEMBLY; DNA METHYLATION; EPIGENESIS, GENETIC; HEMODYNAMICS; HISTONE DEACETYLASES; HISTONES; HUMANS; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; STRESS, PHYSIOLOGICAL;

EID: 84877058605     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12031     Document Type: Article

References (92)

1. Butcher DT, Alliston T, Weaver VM. A tense situation: forcing tumour progression. Nat Rev Cancer. 2009; 9: 108-22.
2. Chiu JJ, Chien S. Effects of disturbed flow on vascular endothelium: pathophysiological basis and clinical perspectives. Physiol Rev. 2011; 91: 327-87.
3. Jaalouk DE, Lammerding J. Mechanotransduction gone awry. Nat Rev Mol Cell Biol. 2009; 10: 63-73.
4. Hahn C, Schwartz MA. Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol. 2009; 10: 53-62.
5. Van Speybroeck L. From epigenesis to epigenetics: the case of C. H. Waddington. Ann NY Acad Sci. 2002; 981: 61-81.
6. Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell. 2007; 128: 635-8.
7. Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010; 28: 1057-68.
8. Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013; 38: 23-38.
9. Kouzarides T. Chromatin modifications and their function. Cell. 2007; 128: 693-705.
10. Winter J, Jung S, Keller S, et al. Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol. 2009; 11: 228-34.
11. Chien S. Mechanotransduction and endothelial cell homeostasis: the wisdom of the cell. Am J Physiol Heart Circ Physiol. 2007; 292: H1209-24.
12. Nguyen CT, Lu Q, Wang Y, et al. Zebrafish as a model for cardiovascular development and disease. Drug Discov Today Dis Models. 2008; 5: 135-40.
13. Hove JR, Koster RW, Forouhar AS, et al. Intracardiac fluid forces are an essential epigenetic factor for embryonic cardiogenesis. Nature. 2003; 421: 172-7.
14. Lucitti JL, Jones EA, Huang C, et al. Vascular remodeling of the mouse yolk sac requires hemodynamic force. Development. 2007; 134: 3317-26.
15. North TE, Goessling W, Peeters M, et al. Hematopoietic stem cell development is dependent on blood flow. Cell. 2009; 137: 736-48.
16. Adamo L, Naveiras O, Wenzel PL, et al. Biomechanical forces promote embryonic haematopoiesis. Nature. 2009; 459: 1131-5.
17. Chiu JJ, Wang DL, Chien S, et al. Effects of disturbed flow on endothelial cells. J Biomech Eng. 1998; 120: 2-8.
18. Berk BC, Abe JI, Min W, et al. Endothelial atheroprotective and anti-inflammatory mechanisms. Ann NY Acad Sci. 2001; 947: 93-109; discussion -11.
19. Jo H, Sipos K, Go YM, et al. Differential effect of shear stress on extracellular signal-regulated kinase and N-terminal Jun kinase in endothelial cells. Gi2- and Gbeta/gamma-dependent signaling pathways. J Biol Chem. 1997; 272: 1395-401.
20. Li YS, Haga JH, Chien S. Molecular basis of the effects of shear stress on vascular endothelial cells. J Biomech. 2005; 38: 1949-71.
21. Akimoto S, Mitsumata M, Sasaguri T, et al. Laminar shear stress inhibits vascular endothelial cell proliferation by inducing cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1). Circ Res. 2000; 86: 185-90.
22. Satcher R, Dewey CF Jr, Hartwig JH. Mechanical remodeling of the endothelial surface and actin cytoskeleton induced by fluid flow. Microcirculation. 1997; 4: 439-53.
23. Matthews BD, Overby DR, Mannix R, et al. Cellular adaptation to mechanical stress: role of integrins, Rho, cytoskeletal tension and mechanosensitive ion channels. J Cell Sci. 2006; 119: 508-18.
24. Li S, Chen BP, Azuma N, et al. Distinct roles for the small GTPases Cdc42 and Rho in endothelial responses to shear stress. J Clin Invest. 1999; 103: 1141-50.
25. Boon RA, Horrevoets AJ. Key transcriptional regulators of the vasoprotective effects of shear stress. Hamostaseologie. 2009; 29: 39-40, 1-3.
26. Wang N, Miao H, Li YS, et al. Shear stress regulation of Kruppel-like factor 2 expression is flow pattern-specific. Biochem Biophys Res Commun. 2006; 341: 1244-51.
27. Li C, Xu Q. Mechanical stress-initiated signal transductions in vascular smooth muscle cells. Cell Signal. 2000; 12: 435-45.
28. Haga JH, Li YS, Chien S. Molecular basis of the effects of mechanical stretch on vascular smooth muscle cells. J Biomech. 2007; 40: 947-60.
29. Lemarie CA, Tharaux PL, Lehoux S. Extracellular matrix alterations in hypertensive vascular remodeling. J Mol Cell Cardiol. 2010; 48: 433-9.
30. Asanuma K, Magid R, Johnson C, et al. Uniaxial strain upregulates matrix-degrading enzymes produced by human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2003; 284: H1778-84.
31. Watase M, Awolesi MA, Ricotta J, et al. Effect of pressure on cultured smooth muscle cells. Life Sci. 1997; 61: 987-96.
32. Birukov KG, Shirinsky VP, Stepanova OV, et al. Stretch affects phenotype and proliferation of vascular smooth muscle cells. Mol Cell Biochem. 1995; 144: 131-9.
33. Li C, Wernig F, Leitges M, et al. Mechanical stress-activated PKCdelta regulates smooth muscle cell migration. FASEB J. 2003; 17: 2106-8.
34. Esteller M. Epigenetics in evolution and disease. Lancet. 2008; 372: S90-6.
35. Reik W, Dean W, Walter J. Epigenetic reprogramming in mammalian development. Science. 2001; 293: 1089-93.
36. Deplus R, Brenner C, Burgers WA, et al. Dnmt3L is a transcriptional repressor that recruits histone deacetylase. Nucleic Acids Res. 2002; 30: 3831-8.
37. Rao X, Zhong J, Zhang S, et al. Loss of methyl-CpG-binding domain protein 2 enhances endothelial angiogenesis and protects mice against hind-limb ischemic injury. Circulation. 2011; 123: 2964-74.
38. Luger K, Mader AW, Richmond RK, et al. Crystal structure of the nucleosome core particle at 2.8 A resolution. Nature. 1997; 389: 251-60.
39. Sterner DE, Berger SL. Acetylation of histones and transcription-related factors. Microbiol Mol Biol Rev. 2000; 64: 435-59.
40. Spin JM, Quertermous T, Tsao PS. Chromatin remodeling pathways in smooth muscle cell differentiation, and evidence for an integral role for p300. PLoS ONE. 2010; 5: e14301.
41. Haberland M, Montgomery RL, Olson EN. The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2009; 10: 32-42.
42. Witt O, Deubzer HE, Milde T, et al. HDAC family: what are the cancer relevant targets? Cancer Lett. 2009; 277: 8-21.
43. Wang GG, Allis CD, Chi P. Chromatin remodeling and cancer, Part I: covalent histone modifications. Trends Mol Med. 2007; 13: 363-72.
44. Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov. 2006; 5: 769-84.
45. Xu WS, Parmigiani RB, Marks PA. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene. 2007; 26: 5541-52.
46. Kim HJ, Bae SC. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res. 2011; 3: 166-79.
47. Lusser A, Kadonaga JT. Chromatin remodeling by ATP-dependent molecular machines. BioEssays. 2003; 25: 1192-200.
48. Mattick JS. The genetic signatures of noncoding RNAs. PLoS Genet. 2009; 5: e1000459.
49. Stefani G, Slack FJ. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol. 2008; 9: 219-30.
50. Erwin JA, Lee JT. New twists in X-chromosome inactivation. Curr Opin Cell Biol. 2008; 20: 349-55.
51. Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature. 2011; 469: 336-42.
52. Weber C, Schober A, Zernecke A. MicroRNAs in arterial remodelling, inflammation and atherosclerosis. Curr Drug Targets. 2010; 11: 950-6.
53. Denli AM, Tops BB, Plasterk RH, et al. Processing of primary microRNAs by the Microprocessor complex. Nature. 2004; 432: 231-5.
54. Chendrimada TP, Gregory RI, Kumaraswamy E, et al. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature. 2005; 436: 740-4.
55. Gregory RI, Chendrimada TP, Cooch N, et al. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell. 2005; 123: 631-40.
56. Fish JE, Santoro MM, Morton SU, et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008; 15: 272-84.
57. Harris TA, Yamakuchi M, Ferlito M, et al. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA. 2008; 105: 1516-21.
58. Cordes KR, Sheehy NT, White MP, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009; 460: 705-10.
59. Tai SC, Robb GB, Marsden PA. Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel. Arterioscler Thromb Vasc Biol. 2004; 24: 405-12.
60. Illi B, Nanni S, Scopece A, et al. Shear stress-mediated chromatin remodeling provides molecular basis for flow-dependent regulation of gene expression. Circ Res. 2003; 93: 155-61.
61. Fish JE, Matouk CC, Rachlis A, et al. The expression of endothelial nitric-oxide synthase is controlled by a cell-specific histone code. J Biol Chem. 2005; 280: 24824-38.
62. Lund G, Andersson L, Lauria M, et al. DNA methylation polymorphisms precede any histological sign of atherosclerosis in mice lacking apolipoprotein E. J Biol Chem. 2004; 279: 29147-54.
63. Post WS, Goldschmidt-Clermont PJ, Wilhide CC, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res. 1999; 43: 985-91.
64. Kim J, Kim JY, Song KS, et al. Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim Biophys Acta. 2007; 1772: 72-80.
65. Zeng L, Zhang Y, Chien S, et al. The role of p53 deacetylation in p21Waf1 regulation by laminar flow. J Biol Chem. 2003; 278: 24594-9.
66. Lee DY, Lee CI, Lin TE, et al. Role of histone deacetylases in transcription factor regulation and cell cycle modulation in endothelial cells in response to disturbed flow. Proc Natl Acad Sci USA. 2012; 109: 1967-72.
67. Zampetaki A, Zeng L, Margariti A, et al. Histone deacetylase 3 is critical in endothelial survival and atherosclerosis development in response to disturbed flow. Circulation. 2010; 121: 132-42.
68. Zeng L, Xiao Q, Margariti A, et al. HDAC3 is crucial in shear- and VEGF-induced stem cell differentiation toward endothelial cells. J Cell Biol. 2006; 174: 1059-69.
69. Chen W, Bacanamwo M, Harrison DG. Activation of p300 histone acetyltransferase activity is an early endothelial response to laminar shear stress and is essential for stimulation of endothelial nitric-oxide synthase mRNA transcription. J Biol Chem. 2008; 283: 16293-8.
70. Huddleson JP, Ahmad N, Srinivasan S, et al. Induction of KLF2 by fluid shear stress requires a novel promoter element activated by a phosphatidylinositol 3-kinase-dependent chromatin-remodeling pathway. J Biol Chem. 2005; 280: 23371-9.
71. Illi B, Dello Russo C, Colussi C, et al. Nitric oxide modulates chromatin folding in human endothelial cells via protein phosphatase 2A activation and class II histone deacetylases nuclear shuttling. Circ Res. 2008; 102: 51-8.
72. Wang W, Ha CH, Jhun BS, et al. Fluid shear stress stimulates phosphorylation-dependent nuclear export of HDAC5 and mediates expression of KLF2 and eNOS. Blood. 2010; 115: 2971-9.
73. Wang YH, Yan ZQ, Qi YX, et al. Normal shear stress and vascular smooth muscle cells modulate migration of endothelial cells through histone deacetylase 6 activation and tubulin acetylation. Ann Biomed Eng. 2010; 38: 729-37.
74. Yan ZQ, Yao QP, Zhang ML, et al. Histone deacetylases modulate vascular smooth muscle cell migration induced by cyclic mechanical strain. J Biomech. 2009; 42: 945-8.
75. Chen Z, Peng IC, Cui X, et al. Shear stress, SIRT1, and vascular homeostasis. Proc Natl Acad Sci USA. 2010; 107: 10268-73.
76. Stein S, Matter CM. Protective roles of SIRT1 in atherosclerosis. Cell Cycle. 2011; 10: 640-7.
77. Cardinale JP, Sriramula S, Pariaut R, et al. HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats. Hypertension. 2010; 56: 437-44.
78. Bogaard HJ, Mizuno S, Hussaini AA, et al. Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. Am J Respir Crit Care Med. 2011; 183: 1402-10.
79. Usui T, Okada M, Hara Y, et al. Exploring calmodulin-related proteins, which mediate development of hypertension, in vascular tissues of spontaneous hypertensive rats. Biochem Biophys Res Commun. 2011; 405: 47-51.
80. Balligand JL, Feron O, Dessy C. eNOS activation by physical forces: from short-term regulation of contraction to chronic remodeling of cardiovascular tissues. Physiol Rev. 2009; 89: 481-534.
81. Wu W, Xiao H, Laguna-Fernandez A, et al. Flow-dependent regulation of Kruppel-Like factor 2 Is mediated by microRNA-92a. Circulation. 2011; 124: 633-41.
82. Nicoli S, Standley C, Walker P, et al. MicroRNA-mediated integration of haemodynamics and Vegf signalling during angiogenesis. Nature. 2010; 464: 1196-200.
83. Qin X, Wang X, Wang Y, et al. MicroRNA-19a mediates the suppressive effect of laminar flow on cyclin D1 expression in human umbilical vein endothelial cells. Proc Natl Acad Sci USA. 2010; 107: 3240-4.
84. Wang KC, Garmire LX, Young A, et al. Role of microRNA-23b in flow-regulation of Rb phosphorylation and endothelial cell growth. Proc Natl Acad Sci USA. 2010; 107: 3234-9.
85. Fang Y, Shi C, Manduchi E, et al. MicroRNA-10a regulation of proinflammatory phenotype in athero-susceptible endothelium in vivo and in vitro. Proc Natl Acad Sci USA. 2010; 107: 13450-5.
86. Ni CW, Qiu H, Jo H. MicroRNA-663 upregulated by oscillatory shear stress plays a role in inflammatory response of endothelial cells. Am J Physiol Heart Circ Physiol. 2011; 300: H1762-9.
87. Zhou J, Wang KC, Wu W, et al. MicroRNA-21 targets peroxisome proliferators-activated receptor-alpha in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc Natl Acad Sci USA. 2011; 108: 10355-60.
88. Hastings NE, Simmers MB, McDonald OG, et al. Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming. Am J Physiol Cell Physiol. 2007; 293: C1824-33.
89. Mohamed JS, Lopez MA, Boriek AM. Mechanical stretch up-regulates microRNA-26a and induces human airway smooth muscle hypertrophy by suppressing glycogen synthase kinase-3beta. J Biol Chem. 2010; 285: 29336-47.
90. Wu WH, Hu CP, Chen XP, et al. MicroRNA-130a mediates proliferation of vascular smooth muscle cells in hypertension. Am J Hypertens. 2011; 24: 1087-93.
91. Yu ML, Wang JF, Wang GK, et al. Vascular smooth muscle cell proliferation is influenced by let-7d microRNA and its interaction with KRAS. Circ J. 2011; 75: 703-9.
92. Raines EW. The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease. Int J Exp Pathol. 2000; 81: 173-82.